Various pharmaceutical products for systemic use

Finnish Institute for Health and Welfare, later referred to as THL or Customer, requested tenders for "Various pharmaceutical products for systemic use" to the rescEU Medical -project. The Scope of procurement is described in more detail in Annex 1 to the Call for tenders. The procurement is divided in three (3) lots. Each product constitutes a separate lot. Tender may be submitted for one or several lots. LOT 1: Ephedrine hydrochlorid 3 mg/ml (10 ml, i.v. solution, ATC C01CA26) LOT 2: Rocuronium bromid 10 mg/ml (5 ml, i.v. solution, ATC M03AC09) LOT 3: Claritromycin oral suspension 50 mg/ml (50 ml, oral suspension ATC J01FA09) The minimum requirements for the products are described in Annex 1.1 to the Call for tenders. The Contract will be awarded to one Supplier for each lot based on a comparison of tenders. Tender that is economically the most advantageous will win the competition. The contract period shall enter into force once the Contract has been signed by contracting parties and expires when all contractual duties of the Contract have been performed. Quantity for the products is described in Annex 7 to the Call for tenders (restricted to security classification level IV, TL IV). In addition to the quantity indicated in the Annex 7, the Customer is entitled to purchase 100 % extra to the quantities (later referred as "Option"). The Supplier is not obliged to deliver the products under the Option. Please note that all times given in the Call for tenders refer to local time in Finland. Call for tenders, Annexes: Annex 1 Scope of the procurement Annex 1.1 Minimum requirements Annex 2 Description of the rotation Annex 2.1 Quality scoring table Annex 3 Contract Annex 4 Security annex Annex 5 JYSE 2014 SUPPLIES (updated version of April 2022) Annex 6 Confidentiality commitment Annex 7 Quantity of the Articles (restricted, TL IV) Please note that the numbering of the annexes differs between the Contract and the Call for tenders. The numbering of the Annexes to the Contract is based on the order of precedence applied in the Contract.

The availability for the Annex 7 is restricted to security classification level IV (TL IV). THL will send the Annex 7 to a representative of the tenderer via encrypted email after THL has received a scanned version of the signed Confidentiality commitment (Annex 6). The signature of the Confidentiality commitment shall be done manually by hand. Confidentiality commitment shall be signed by a legal representative of tenderer. Confidentiality commitment shall be sent to the email address kirjaamo@thl.fi with the subject line "CONFIDENTIALITY COMMITMENT - THL/278/2.02.06/2025 / Various pharmaceutical products for systemic use". The message shall contain name of the tenderer and email address to which the Annex 7 is to be sent.